For patients focused on body composition (building lean mass while reducing body fat), some providers recommend pairing IGF-1 LR3 with a GLP-1 microdose protocol
The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19
In randomized controlled trials of semaglutide, participants lost on average 14.9-17.6% of their baseline weight over 68 weeks, according to a study cited in Statnews.com.(6) For the GLP-1 tirzepatide, average losses reached 21.4% at the highest studied dose over 72 weeks.(7) All groups in the controlled trials also received counseling on diet and exercise
Mollan, MBChB, FRCOphth, PhD Honorary professor, University of Birmingham, EnglandConsultant neuro-ophthalmologist, University Hospitals Birmingham, England Disclosures: Mollan reports receiving grants or research income paid to her institution from National Institute of Health Research, UK Space Agency and Idiopathic Intracranial Hypertension UK
This guide highlights the benefits of Tirzepatide with B12, providing essential information to help you understand its potential
For optimal results and safety, semaglutide should be used under medical supervision, accompanied by lifestyle modifications like a balanced diet and regular exercise
